title: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
authors.forename: George F
authors.initials: GF
authors.lastname: Van Hare
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Ackerman
authors.forename: Juli-Anne K
authors.initials: JA
authors.lastname: Evangelista
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Kovacs
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Myerburg
authors.forename: Keri M
authors.initials: KM
authors.lastname: Shafer
authors.forename: Carole A
authors.initials: CA
authors.lastname: Warnes
authors.forename: Reginald L
authors.initials: RL
authors.lastname: Washington
mesh_terms: D026683:Advisory Committees / Q000592:standards*; D000572:American Heart Association; D056352:Athletes; D002309:Cardiology / Q000379:methods / Q000592:standards*; D006330:Heart Defects, Congenital / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards*; D014481:United States / Q000453:epidemiology
keywords: AHA Scientific Statements; Fontan procedure; athletes; cardiovascular abnormalities; congenital heart disease; coronary vessel anomalies; transposition of great arteries